Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Male infertility or hypogonadism" and "Society guideline links: Male sexual dysfunction".)
International
●Endocrine Society (ES): Clinical practice guideline on testosterone therapy in men with hypogonadism (2018)
Canada
●Choosing Wisely Canada: Don't order serum testosterone in men without symptoms of hypogonadism (updated 2017)
●Choosing Wisely Canada: Don't prescribe testosterone therapy unless there is biochemical evidence of testosterone deficiency (updated 2017)
United States
●Choosing Wisely: Don't prescribe testosterone to men with erectile dysfunction who have normal testosterone levels (2013, updated 2018)
●US Food and Drug Administration (FDA): Testosterone information (updated 2015)
Europe
●European Association of Urology (EAU): Guidelines on sexual and reproductive health (2018)
United Kingdom
Australia-New Zealand
●ESA: Position statement on male hypogonadism (part 2) – Treatment and therapeutic considerations (2016)
Japan